Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Thrombosis and Haemostasis

• Publication date

  2016-12-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1160/TH16-09-0716PMID 27929200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C‐reactive protein, obesity, and the risk of arterial and venous thrombosis

  2016influential reference
• EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

  2016cited by this paper
• Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab).

  2016cited by this paper
• Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic Review

  2016cited by this paper
• Clinical Practice Guidelines EASL Clinical Practice Guidelines on the management of benign liver tumours q European Association for the Study of the Liver ( EASL ) ⇑

  2016cited by this paper
• Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.

  2014influential reference
• Hemophilia B Leyden and once mysterious cis-regulatory mutations.

  2014cited by this paper
• A population-based study on the prevalence of NASH using scores validated against liver histology.

  2014cited by this paper
• Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3

  2013cited by this paper
• Fibrinogen gene regulation

  2012cited by this paper
• Obesity‐Related Derangements of Coagulation and Fibrinolysis: A Study of Obesity‐Discordant Monozygotic Twin Pairs

  2012cited by this paper
• Modulation of Mouse Coagulation Gene Transcription following Acute In Vivo Delivery of Synthetic Small Interfering RNAs Targeting HNF4α and C/EBPα

  2012cited by this paper
• Innate Immune Cells in Liver Inflammation

  2012cited by this paper
• Increased coagulation factor VIII, IX, XI and XII activities in non‐alcoholic fatty liver disease

  2011cited by this paper
• Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

  2011cited by this paper
• Twist1 in human white adipose tissue and obesity.

  2011cited by this paper
• Hemostasis and thrombosis in patients with liver disease: the ups and downs.

  2010cited by this paper
• Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion.

  2010cited by this paper
• Reduced Time Points to Calculate the Composite Index

  2010cited by this paper
• A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

  2009cited by this paper
• A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis

  2009cited by this paper
• Cardiovascular risk factors in idiopathic compared to riskassociated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP)

  2009cited by this paper
• Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

  2009cited by this paper
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

  2008cited by this paper
• Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 5th ed.

  2007cited by this paper
• Inter‐relationships of interleukin‐6, cardiovascular risk factors and the metabolic syndrome among older men

  2007cited by this paper
• MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.

  2006cited by this paper
• Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

  2006cited by this paper
• CCR2 modulates inflammatory and metabolic effects of high-fat feeding.

  2006cited by this paper
• Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

  2005cited by this paper
• Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral adipose tissue

  2005cited by this paper
• Elevated Clotting Factor Levels and Venous Thrombosis

  2003cited by this paper
• The Relation Between Insulin Resistance and Hemostasis: Pleiotropic Genes and Common Environment

  2003cited by this paper
• Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

  2003cited by this paper
• Obesity is associated with macrophage accumulation in adipose tissue.

  2003cited by this paper
• Inhibition of Platelet‐Collagen Interaction An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity

  2002cited by this paper
• The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

  2001cited by this paper
• The Factor VIII Acute Phase Response Requires the Participation of NFκB and C/EBP

  2000cited by this paper
• Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

  1999cited by this paper
• Tissue factor in atherosclerosis.

  1999cited by this paper
• Transcriptional Activation of the Factor VIII Gene in Liver Cell Lines by Interleukin-6

  1998cited by this paper
• Liver Steatosis and Its Relation to Plasma Haemostatic Factors in Apparently Healthy Men - Role of the Metabolic Syndrome

  1996cited by this paper
• Factor VIII, ABO blood group and the incidence of ischaemic heart disease

  1994influential reference
• COAGULATION FACTOR XIII A AND B SUBUNITS IN BONE MARROW AND LIVER TRANSPLANTATION

  1987cited by this paper
• Hemostasis and thrombosis: Basic principles and clinical practice

  1987cited by this paper
• Assay of glucose transport in human fat cells obtained by needle biopsy

  1986cited by this paper
• Distribution of factor VIII mRNA and antigen in human liver and other tissues

  1985cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Hemostasis and Thrombosis—Basic Principles and Clinical Practice

  1983cited by this paper
• Thrombotest. A new method for controlling anticoagulant therapy.

  1959cited by this paper

• Association between the triglyceride–glucose index and left atrial appendage thrombogenic milieu in patients with atrial fibrillation

  2025cites this paper
• Network pharmacology combined with untargeted metabolomics reveals the intervention mechanism and compatibility of chenpi-rougui herb pair in nonalcoholic fatty liver disease

  2025cites this paper
• Function of PNPLA3 I148M—Lessons From In Vivo Studies in Humans

  2025influential citation
• Outcomes of endovascular thrombectomy in acute ischemic stroke patients with insulin resistance

  2025cites this paper
• Calculated whole blood viscosity in non-diabetic subjects with asymptomatic carotid atherosclerosis: How insulin resistance may affect blood viscosity

  2024cites this paper
• Factor XII signaling via uPAR-integrin β1 axis promotes tubular senescence in diabetic kidney disease

  2024influential citation
• Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

  2024cites this paper
• A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle

  2024cites this paper
• Hyperglycemia and Venous Thromboembolism

  2024cites this paper
• Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease.

  2023cites this paper
• Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist

  2023cites this paper
• α1-Adrenergic Stimulation Increases Platelet Adhesion to Endothelial Cells Mediated by TRPC6.

  2023cites this paper
• Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients

  2022cites this paper
• Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications

  2022cites this paper
• The Influence of Different Types of Diabetes on Vascular Complications

  2022cites this paper
• Factor XIII-A Val34Leu and Tyr204Phe variants influence clot kinetics in a cohort of South African type 2 diabetes mellitus patients.

  2022cites this paper
• Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis

  2021cites this paper
• Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome

  2021cites this paper
• Non-alcoholic fatty liver disease – a procoagulant condition?

  2021cites this paper
• Linking liver metabolic and vascular disease via bile acid signaling.

  2021cites this paper
• Prise en charge diagnostique et thérapeutique de la maladie veineuse thromboembolique chez le patient obèse

  2020cites this paper
• [Diagnostic and therapeutic management of venous thromboembolic disease in obese patients].

  2020cites this paper
• Metabolic Consequences Of Obesity On The Hypercoagulable State Of Polycystic Ovary Syndrome: A Risk For Severe SARS-Cov-2 Infection?

  2020cites this paper
• Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.

  2019cites this paper
• Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin

  2018cites this paper
• Suppressing Irf2bp2 expressions accelerates metabolic syndrome-associated brain injury and hepatic dyslipidemia.

  2018cites this paper
• Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future

  2018cites this paper
• Comparative omics and feeding manipulations in chicken indicate a shift of the endocrine role of visceral fat towards reproduction

  2018cites this paper
• Mice with diet-induced obesity demonstrate a relative prothrombotic factor profile and a thicker aorta with reduced ex-vivo function

  2018cites this paper
• Prothrombotic state in young females with severe early-onset obesity

  2018cites this paper
• ’ Choice in the 60 th Anniversary Year of Thrombosis and Haemostasis : Past , Present and Future

  2017cites this paper